Susan Moran's Colleagues at QED Therapeutics
Susan Moran's Contact Details
HQ
650-231-4088
650-231-4088
Location
Ireland
Ireland
Company
QED Therapeutics
QED Therapeutics
Susan Moran's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Susan Moran
Susan Moran currently works for QED Therapeutics.
Susan Moran's role at QED Therapeutics is Chief Medical Officer.
Susan Moran's email address is ***@qedtx.com. To view Susan Moran's full email address, please signup to ConnectPlex.
Susan Moran works in the Biotechnology industry.
Susan Moran's colleagues at QED Therapeutics are Jessica Meidinger, Miki Yamamoto, Scott Collins, Dawn Hill, Mike Monteith, Stacie Shepherd, Todd Bobick and others.
Susan Moran's phone number is 650-231-4088